05.13.11
Dr. Reddy’s 4Q10
4Q Revenues: $453.0 million (+23%)
4Q Earnings: $75.0 million (+101%)
FY Revenues: $1.7 billion (+6%)
FY Earnings: $248.0 million (earnings were $24.0 million FY10)
Comments: North America revenue growth was 18% for the year, with 11 new product launches. Russia had revenue growth of 29% with volume growth and OTC initiatives. India had revenue growth of 15%, with continued growth of key brands and new products. Germany revenue was down 17% in Euro terms, but had improved profitability. Global Generics revenue was $1.2 billion for the year (+10%), led by performance in North America and Emerging Markets.
4Q Revenues: $453.0 million (+23%)
4Q Earnings: $75.0 million (+101%)
FY Revenues: $1.7 billion (+6%)
FY Earnings: $248.0 million (earnings were $24.0 million FY10)
Comments: North America revenue growth was 18% for the year, with 11 new product launches. Russia had revenue growth of 29% with volume growth and OTC initiatives. India had revenue growth of 15%, with continued growth of key brands and new products. Germany revenue was down 17% in Euro terms, but had improved profitability. Global Generics revenue was $1.2 billion for the year (+10%), led by performance in North America and Emerging Markets.